ホーム › PubMed Lab 🤖 自分の AI で使う ⭐ 保存した論文

🔬 PubMed Lab

日本語で入力するだけで、PubMed の英語論文を検索できるリサーチアシスタントです。
卒論・研究テーマ探し、興味のある論文を効率よく見つけられます。

「大腸がん免疫療法、腸内細菌の介入で効果改善の可能性が示唆」の検索結果

224 件中 10 件を表示 (4364 ms) · ⭐ 保存した論文

AI が生成した英語クエリを見る
("colorectal neoplasms"[MeSH] OR "colorectal cancer" OR "colon cancer") AND (immunotherapy[MeSH] OR "immune checkpoint inhibitors" OR "cancer immunotherapy") AND ("gastrointestinal microbiome"[MeSH] OR "gut microbiota" OR "intestinal bacteria" OR microbiome) AND (intervention OR modulation OR manipulation)

💡 大腸がん、免疫療法、腸内細菌の介入による効果改善をカバーする包括的クエリ。MeSH用語と同義語を組み合わせて網羅性を確保。

🎓 卒論・修論テーマを AI が提案

この 5 本の論文を俯瞰して、あなたが実際に卒論・修論で研究できるテーマを 3 つ提案します。

残り 3 / 3 回 (今日)

📖 このサイトの解説記事から (日本語で読める)

PubMed Trivia が過去に取り上げた論文を日本語で解説している記事です。

🔍 PubMed の検索結果

  • Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer.

    Dingjiacheng Jia, Qiwen Wang, Yadong Qi 他 · Cell · 2024

    The immune checkpoint blockade (ICB) response in human cancers is closely linked to the gut microbiota. Here, we report that the abundance of commensal Lactobacillus johnsonii is positively correlated with the responsiveness of ICB. Supplementation with Lactobacillus johnsonii or tryptophan-derived metabolite indole-3-propionic acid (IPA) enhances the efficacy of CD8+ T cell-mediated αPD-1 immunot…

    📄 PubMed で読む (PMID: 38490195)
  • Potential Role of the Gut Microbiome In Colorectal Cancer Progression.

    Jaeho Kim, Heung Kyu Lee · Frontiers in immunology · 2021

    An increasing number of studies have revealed that the progression of colorectal cancer (CRC) is related to gut microbiome composition. Under normal conditions, the gut microbiome acts as a barrier to other pathogens or infections in the intestine and modulates inflammation by affecting the host immune system. These gut microbiota are not only related to the intestinal inflammation associated with…

    📄 PubMed で読む (PMID: 35069592)
  • The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health.

    Bianca J Parker, Pamela A Wearsch, Alida C M Veloo 他 · Frontiers in immunology · 2020

    Alistipes is a relatively new genus of bacteria isolated primarily from medical clinical samples, although at a low rate compared to other genus members of the Bacteroidetes phylum, which are highly relevant in dysbiosis and disease. According to the taxonomy database at The National Center for Biotechnology Information, the genus consists of 13 species: Alistipes finegoldii, Alistipes putredinis,…

    📄 PubMed で読む (PMID: 32582143)
  • Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis.

    Winnie Fong, Qing Li, Fenfen Ji 他 · Gut · 2023

    Gut microbiota is a key player in dictating immunotherapy response. We aimed to explore the immunomodulatory effect of probiotic Lactobacillus gallinarum and its role in improving anti-programmed cell death protein 1 (PD1) efficacy against colorectal cancer (CRC). The effects of L. gallinarum in anti-PD1 response were assessed in syngeneic mouse models and azoxymethane/dextran sulfate sodium-induc…

    📄 PubMed で読む (PMID: 37770127)
  • The role of the gut microbiota in tumor, immunity, and immunotherapy.

    Yuyan Xie, Fang Liu · Frontiers in immunology · 2024

    In recent years, with the deepening understanding of the gut microbiota, it has been recognized to play a significant role in the development and progression of diseases. Particularly in gastrointestinal tumors, the gut microbiota influences tumor growth by dysbiosis, release of bacterial toxins, and modulation of host signaling pathways and immune status. Immune checkpoint inhibitors (ICIs) have …

    📄 PubMed で読む (PMID: 38903520)
  • Single-cell transcriptomic analysis reveals gut microbiota-immunotherapy synergy through modulating tumor microenvironment.

    Minyuan Cao, Yun Deng, Qing Hao 他 · Signal transduction and targeted therapy · 2025

    The gut microbiota crucially regulates the efficacy of immune checkpoint inhibitor (ICI) based immunotherapy, but the underlying mechanisms remain unclear at the single-cell resolution. Using single-cell RNA sequencing and subsequent validations, we investigate gut microbiota-ICI synergy by profiling the tumor microenvironment (TME) and elucidating critical cellular interactions in mouse models. O…

    📄 PubMed で読む (PMID: 40312419)
  • Immunotherapy in microsatellite-stable colorectal cancer: Strategies to overcome resistance.

    Engeng Chen, Wei Zhou · Critical reviews in oncology/hematology · 2025

    Colorectal cancer (CRC) is among the foremost causes of cancer-related mortality worldwide; however, individuals with microsatellite-stable (MSS) disease-who constitute most CRC diagnoses-derive limited benefit from existing immunotherapeutic approaches. Here, we outline emerging methods designed to address the inherent resistance of MSS CRC to immune checkpoint inhibitors (ICIs). Recent findings …

    📄 PubMed で読む (PMID: 40409481)
  • Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy.

    Andrea Nicolini, Paola Ferrari · Frontiers in immunology · 2024

    Metabolic reprogramming is a k`ey hallmark of tumors, developed in response to hypoxia and nutrient deficiency during tumor progression. In both cancer and immune cells, there is a metabolic shift from oxidative phosphorylation (OXPHOS) to aerobic glycolysis, also known as the Warburg effect, which then leads to lactate acidification, increased lipid synthesis, and glutaminolysis. This reprogrammi…

    📄 PubMed で読む (PMID: 39119332)
  • Herbal Medicine for Colorectal Cancer Treatment: Molecular Mechanisms and Clinical Applications.

    Zuqing Su, Yanlin Li, Zihao Zhou 他 · Cell proliferation · 2025

    Colorectal cancer (CRC) is one of the most common malignant tumours and is the second leading cause of cancer-related mortality worldwide. Despite the availability of preventative, diagnostic and treatment methods including endoscopic treatment, surgical intervention, radiotherapy, biologics, salvage therapy and immunotherapy, the mortality rate associated with CRC remains alarming. Consequently, …

    📄 PubMed で読む (PMID: 40488304)
  • Tumor-associated macrophages in colon cancer immunotherapy: mechanisms, natural product interventions, and microenvironment remodeling.

    Qingman He, Li Xiang, Yuanyuan Luo 他 · Frontiers in immunology · 2025

    Colon cancer persists as a major global health burden due to therapy resistance and metastasis, with tumor-associated macrophages (TAMs) in the microenvironment driving progression through immune evasion and angiogenesis. This review highlights plant-derived therapeutics targeting TAMs to disrupt protumor signaling. Key phytochemicals (e.g., Curcumin, Cucurbitacin B, Astragaloside IV) suppress M2 …

    📄 PubMed で読む (PMID: 40873588)